Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2022

Equity [Abstract]

Cash Dividends Declared

The following table details our cash dividends declared and paid in 2022 through the date hereof:

					(Dollars in thousands)
Declaration Date	Record Date	Payment Date	Per Share Amount		Total Declared(1)
February 16, 2022	March 16, 2022	March 30, 2022	$	0.3125	$	6,513
Total			$	0.3125	$	6,513

(1) The total declared reflects the cash dividends declared in relation to common stock, deferred stock units ("DSUs") and unvested RSUs.

Basic and Diluted Net Loss Per Common Shares

The components of basic and diluted net (loss) per common share were as follows for the periods stated:

	For the Three Months Ended March 31,
(in thousands, except for share and per share amounts)	2022		2021
Numerator:
Net loss	$	(7,214)	$	(2,297)
Denominator:
Basic and diluted weighted average common shares outstanding	19,599,526		19,272,786
Basic and diluted net loss per common share	$	(0.37)	$	(0.12)

Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

For the three months ended March 31, 2022, and 2021 the following securities were excluded from the calculation of diluted shares outstanding as the effect would have been anti-dilutive:

	For the Three Months Ended March 31,
	2022	2021
Restricted stock units	270,225	292,059

Activities Under Equity Plan

The following table summarizes the activities under the Equity Plans from January 1, 2022, through March 31, 2022:

	Activity
Total equity securities available at January 1, 2022	990,129
RSU, DSU, and restricted stock awarded to eligible employees, net of forfeitures	(443,901)
Total equity securities available at March 31, 2022	546,228

The following table summarizes the activities under the ESPP from January 1, 2022, through March 31, 2022:

	Activity
Total ESPP equity securities available at January 1, 2022	133,184
ESPP common stock purchased by eligible employees	—
Total ESPP securities available at March 31, 2022	133,184

Summary of Outstanding RSUs

The following table details activities with respect to outstanding RSUs, DSUs, and restricted stock under the Equity Plans for the three months ended March 31, 2022:

	Shares	Weighted- Average Grant Date Fair Value
Unvested at January 1, 2022	771,171	$	11.24
Granted	454,429	8.65
Vested	(12,890)	11.10
Forfeited	(10,390)	11.92
Unvested at March, 31 2022	1,202,320	$	10.26

Stock Based Compensation Expense

The following table reflects the items for stock-based compensation expense in the Condensed Consolidated Statements of Operations for the periods stated:

	For the Three Months Ended March 31,
(Dollars in thousands)	2022		2021
Performance-based RSUs	$	460	$	573
Time-based RSUs, DSUs and restricted stock	655		1,023
Equity in lieu of salary	—		622
ESPP	—		21
Total stock-based compensation	$	1,115	$	2,239